(Q34267385)

1 August 2017

title

Long-acting injectable antipsychotics for the maintenance treatment of bipolar disorder (English)

1 reference

1 August 2017

1 reference

Beny Lafer

2

0 references

author name string

Alexandre Duarte Gigante

series ordinal

1

1 reference

1 August 2017

Lakshmi N Yatham

series ordinal

3

1 reference

1 August 2017

language of work or name

1 reference

1 May 2012

1 reference

1 August 2017

1 reference

1 August 2017

volume

26

1 reference

1 August 2017

issue

5

1 reference

1 August 2017

page(s)

403-420

1 reference

Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F11631310-000000000-00000

Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11631310-000000000-00000

A review of psychosocial outcome in patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11631310-000000000-00000

Neuropsychological functioning in euthymic bipolar disorder: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11631310-000000000-00000

Functional outcomes in first-episode patients with bipolar disorder: a prospective study from the Systematic Treatment Optimization Program for Early Mania project

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11631310-000000000-00000

Functional impairment and disability across mood states in bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11631310-000000000-00000

Functional impairment, stress, and psychosocial intervention in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11631310-000000000-00000

Clinical predictors of functional outcome of bipolar patients in remission.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11631310-000000000-00000

Effects of recurrence on the cognitive performance of patients with bipolar I disorder: implications for relapse prevention and treatment adherence.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11631310-000000000-00000

Clinical and economic consequences of medication non-adherence in the treatment of patients with a manic/mixed episode of bipolar disorder: results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11631310-000000000-00000

Treatment non-adherence in affective disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11631310-000000000-00000

Assessment of medication adherence in a cohort of patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11631310-000000000-00000

Risk of Recurrence Following Discontinuation of Lithium Treatment in Bipolar Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11631310-000000000-00000

Self-reported adherence to treatment with mood stabilizers, plasma levels, and psychiatric hospitalization

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11631310-000000000-00000

Relapse into mania or depression following lithium discontinuation: a 7-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11631310-000000000-00000

Clinical features associated with poor pharmacologic adherence in bipolar disorder: results from the STEP-BD study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11631310-000000000-00000

Psychopharmacology and adverse effects of antipsychotic long-acting injections: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11631310-000000000-00000

First-generation antipsychotic long-acting injections v. oral antipsychotics in schizophrenia: systematic review of randomised controlled trials and observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11631310-000000000-00000

Oral versus depot antipsychotic drugs for schizophrenia--a critical systematic review and meta-analysis of randomised long-term trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11631310-000000000-00000

Medication discontinuation with depot and oral antipsychotics in outpatients with schizophrenia: comparison of matched cohorts from a 12-month observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11631310-000000000-00000

Flupenthixol decanoate in recurrent manic-depressive illness. A comparison with lithium

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11631310-000000000-00000

Depot risperidone in the outpatient management of bipolar disorder: a 2-year study of 10 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11631310-000000000-00000

Risperidone long-acting injectable for maintenance therapy in bipolar disorder: An open-label pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11631310-000000000-00000

A long-term prospective study on the outcome of bipolar patients treated with long-acting injectable risperidone

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11631310-000000000-00000

A randomized, double-blind, placebo-controlled study of maintenance treatment with adjunctive risperidone long-acting therapy in patients with bipolar I disorder who relapse frequently

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11631310-000000000-00000

Risperidone long-acting injectable monotherapy in the maintenance treatment of bipolar I disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11631310-000000000-00000

Suicidal risk in bipolar I disorder patients and adherence to long-term lithium treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11631310-000000000-00000

Utilization of long-acting antipsychotic medication in patient care

21 January 2018

1 reference

12 December 2020

[Efficacy and safety of long-acting injectable risperidone in maintenance phase of bipolar and schizoaffective disorder]

1 reference

12 December 2020

Risks versus benefits of different types of long-acting injectable antipsychotics.

1 reference

12 December 2020

A 6-month randomized open-label comparison of continuation of oral atypical antipsychotic therapy or switch to long acting injectable risperidone in patients with bipolar disorder

1 reference

12 December 2020

Usefulness of long-acting injectable risperidone during 12-month maintenance therapy of bipolar disorder

1 reference

12 December 2020

Use of risperidone long-acting injection to support treatment adherence and mood stabilization in pediatric bipolar patients: a case series.

1 reference

12 December 2020

Use of long-acting risperidone in the treatment of bipolar patients

1 reference

12 December 2020

Suicide in 406 mood-disorder patients with and without long-term medication: a 40 to 44 years' follow-up

1 reference

12 December 2020

Depot neuroleptics and manic depressive psychosis

1 reference

12 December 2020

Correlates of medication adherence among patients with bipolar disorder: results of the bipolar evaluation of satisfaction and tolerability (BEST) study: a nationwide cross-sectional survey

1 reference

12 December 2020

Depot antipsychotics in bipolar affective disorder

1 reference

12 December 2020

Depot injections for affective disorders

1 reference

12 December 2020

Suicides and parasuicides in a high-risk patient group on and off lithium long-term medication

1 reference

12 December 2020

Comparison of the prophylactic action of flupenthixol with placebo in lithium treated manic-depressive patients

1 reference

12 December 2020

Depot antipsychotics in the prophylaxis of bipolar affective disorder

1 reference

12 December 2020

Treatment of rapid cycling affective illness

1 reference

12 December 2020

10.2165/11631310-000000000-00000

Identifiers

DOI

1 reference

Dimensions Publication ID

1 August 2017

1006976182

0 references

Fatcat ID

release_ofaxzfeo7fg57m5ylzpcc6ts5e

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ofaxzfeo7fg57m5ylzpcc6ts5e

24 November 2022

mapped directly with Wikidata item

1 reference